Document is current
Any future updates will be listed below
-
Authors
Caramello, Alessia https://orcid.org/0000-0001-7455-7686
Fancy, Nurun https://orcid.org/0000-0002-6481-6266
Tournerie, Clotilde
Eklund, Maxine
Chau, Vicky
Adair, Emily https://orcid.org/0009-0001-7058-2216
Papageorgopoulou, Marianna
Willumsen, Nanet https://orcid.org/0000-0001-7289-3360
Jackson, Johanna S. https://orcid.org/0000-0002-8459-0591
Hardy, John
Matthews, Paul M. https://orcid.org/0000-0002-1619-8328
-
Funding
Funding for this research was provided by:
UK Dementia Research Institute (UKRI Medical Research Council), Biogen
- License Information
-
More Information
Article History
Received: 3 October 2024
Accepted: 21 May 2025
First Online: 4 June 2025
Competing interests
: This study was partly funded by Biogen. PMM has received consultancy fees from Sudo Biosciences, Ipsen Biopharm Ltd., Rejuveron Therapeutics, Nimbus Therapeutics and Biogen. He has received honoraria or speakers’ fees from Novartis and Biogen and has received research or educational funds from BMS, Biogen, Novartis, Invicro and Nimbus Therapeutics. The remaining authors declare no competing interests.
